Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells invitro

Induction by fibroblast growth factor of angiotensin converting enzyme in vascular endothelial cells invitro

Vol. 145, No. 3, 1987 June 30, 1987 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 1211-1216 INDUCTION BY FIBROBLAST GROWTH FACTOR OF A...

307KB Sizes 3 Downloads 70 Views

Vol. 145, No. 3, 1987 June 30, 1987

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS Pages 1211-1216

INDUCTION BY FIBROBLAST GROWTH FACTOR OF ANGIOTENSIN CONVERTING ENZYME IN VASCULAR ENDOTHELIAL CELLS --IN VITRO Tetsuro

Okabe,

The Third University

Received

Kazuo Hiroshi

Yamagata, Hidaka,

Michio Fujisawa, Fumimaro and Yoshimi Umezawa

Department of Internal Medicine, Faculty of Tokyo, Tokyo 113, Japan, and Department Juntendo University, Tokyo 113, Japan

May 15,

Takaku,

of Medicine, of Pathology,

1987

SUMMARY: Induction of vascular endothelial cells with pituitary fibroblast growth factor (FGF) provoked an increase in angiotensin converting The stimulatory effect of FGF on ACE activity was enzyme activity. dose-dependent (EDso = 1.0 rig/ml). Our results suggest a possible role for pituitary FGF in regulation of ACE production in vascular 0 1987 Academic Press, Inc. endothelial cells.

The by two

production

of angiotensin renin

enzymes;

controlling

release

regulation

functions.

peptidase

located

degrades

bradykinin

of

pressure

isolating chose the shown the growth

and

endothelial cultured

to

of

increase

effects factor

of

largely

ignored.

culture

exhibit

a wide

assigned

cells

have cells

ACE production. ACE production various

on ACE activity

peptide

of

range

vascular

important

roles

fluid

exchange.

established

as a convenient

(2). growth

in endothelial

1211

but

of

to

a carboxydicells,

angiotensin in

the

factors

II.

regulation

Techniques (1).

system

this

the

degradative

report, including

for

We therefore to

investigate

glucocorticoids In

factors

endothelial

I

Recently,

The

enzyme,

angiotensin

been

regulated

studied,

converting

transvascular

endothelial

regulation

has been

surface

is

enzyme.

intensively

converts

been

substrate

been

luminal

and

have

have

renin

converting

Angiotensin

on the

peptides

blood

in

from

angiotensin

renin

cells

synthetic

These

of

of ACE activity

Endothelial and

and

II

have we

been

examined

fibroblast

cells. 0006-291X/87 $1.50 Copyright 0 1987 by Academic Press, Inc. Ail rights of reproduction in any ,form reserved.

Vol. 145, No. 3, 1987

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

MATERIALSANDMETHODS Materials: Fibroblast growth factor (FGF), Epidermal growth factor stimulating activity (MSA), insulin, Triiodo(EW t Multiplication thyronine, and dexamethasone were purchased from Collaborative Research Inc. Heparin, 12-O-tetradecanoylphorbol 13-acetate (TPA), progesterone, estradiol, testosterone, and cholera toxin were obtained from Sigma Chemical Co. Cell culture and medium: Endothelial cells were collected from a fresh porcine aorta using collagenase digestion as described by Booyse et Cloning of the endothelial cells was performed by single cell al (3). platings as described originally by Puck et al (4). The endothelial cells were cultured in plastic dishes (Falcon 3002) in Ham's F-10 nutrient mixture supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and streptomycin (100 us/ml). Subcultures were performed using 0.25% trypsin and 0.02% EDTA solution (Gibco) when the cells reached confluency. There was no evidence of transformation or loss of endothelial monolayer under these conditions. Media, serum, and antibiotics were obtained from Flow Laboratories Inc. Conversion of angiotensin I to angiotensin II by endothelial cells: ACE activity was measured by adding angiotensin I to the cultured endothelial cells and measuring generated angiotensin II by radioimmunoassay as described previously (5). After confluency, the culture medium was removed, and the cells were washed twice with F-10 medium, and then incubated in serum-free F-10 medium in the presence of angiotensin I (final concentration = 12 rig/ml). After 5 hr of incubations at 37°C in a 5% CO%chamber, the medium was harvested and stored at -20°C for later angio ensin II analysis. Simultaneously, as a control, the medium without cells was incubated and harvested. Angiotensins were purchased from Protein Research Foundation, Osaka, Japan. Radioimmunoassay for angiotensin II: The generated angiotensin II was measured by direct radioinununoassay performed according to the Briefly, 700 ul of 0.1 M Tris buffer (pH 7.4) method described (5). containing & mM EDTA and 0.025% bovine serum albumin, and 100 ul of 0.005 uCi I-angiotensin II (approximately 10,000 cpm; New England Nuclear Co.) were mixed with 100 ul angiotensin II antiserum )l : 100,000 titer). The sample (100 ul) was added and the reaction mixture was incubated for 16-20 hr at 4°C. Antibody-bound and free angiotensin II were separated by the addition of a dextran-coated charcol suspension. Bound radioactivity was counted with a [email protected] counter. Without addition of the test sample, 75% of I-angiotensin II was bound to antiserum at a final titer of 1 : 100,000. There was less than 0.5% cross-reactivity to angiotensin I.

RESULTSAND DISCUSSION When the

endothelial

angiotensin

II

(Fig.

Angiotensin

1).

of vascular

cells

were incubated

with

angiotensin

I,

was generated in the medium in a time-dependent manner II

was not generated in the incubation

smooth muscle cells

or without

the endothelial

not shown) that

I 10 nM dexamethasone could

our endothelial

cells

Conversion of angiotensin

in

confirmation I to angiotensin 1212

of II

cells

induce ACE activity the

earlier

report

medium (data in (2).

was increased by incubat-

Vol. 145, No. 3, 1987

BIOCHEMICAL

0

AND BIOPHYSICAL

1

4

8

Incubation Figure

ing

the

cells

with factor(s)

dexamethasone which

fibroblast

growth factor

in the endothelial

cells

in

may be

we examined several

activity,

a dose-related involved

peptide

(FGF)(6).

2.

factors

in

manner. the

regulation

In search of

ACE

and hormones including

FGF was found to induce ACE activity

in a dose dependent manner (Fig.

Dexamethasone (nM) Figure

Time (hrf

Conversion of angiotensin I to angiotensin II in serum-free cultures of vascular endothelial cells. At time = 0, culture medium containing no fetal bovine serum was placed over confluent cultures of endothelial cells in Falcon 60-mm dishes. The generated angiotensin II was measured by direct radioimmunoassay after 1, 4, and 8 hours. Each point represents mean value from three dishes. Bars, S.D.

1.

of peptide

RESEARCH COMMUNICATIONS

2).

The

FGF (rig/ml)

Effect of fibroblast growth factor on ACE activity in endothelial cells. Confluent cultures of endothelfal cells were incubated in serum-free F-10 medium containing various concentrations of pituitary fibroblast growth factor. Conversion of angiotensin I to angiotensin II was examined as described in Fig. 1. The generated angiotensin II was measured after 5 hr of incubations. Each point represents mean value from three dishes. Bars, S.D.

1213

Vol. 145, No. 3, 1987

Figure

other

3.

8lOCHEMlCAL

factors,

cant effects

such as insulin,

epidermal growth factor

stimulating

on the ACE activity.

were strongly

inhibited

(data not shown). 95% by captopril

by treating

factor

has been shown to stimulate

cells.

However, the physiological elucidated.

However, endothelial confluency

(7).

about

was achieved

at

peptide

factors

in the endothelial this

pituitary

angiotensin

2.5-fold

was

not

peptide II.

role of this

Several

3).

glands (6).

The

of mesoderm-derived pituitary

peptide has

FGF has been shown to stimulate

cells

in sparsely populated cultures.

cultures,

within

In

(Fig. may play

FGF was found to induce

24 hr.

Half-maximal

the FGF-treated

significantly

including

cells

for ACE (Fig.

have been shown to cease DNAsynthesis after

1.0 rig/ml.

cells

97% by EDTA (1 mM) and

a wide variety

In the confluent

ACE activities

endothelial

cells

with cycloheximide

from pituitary

Pituitary

the growth of vascular endothelial

of the endothelial

the cells

inhibitor

isolated

(EGF), growth

(MSA) shows no signifi-

was inhibited

(10 uM), a specific

not been fully

activity

The ACE activity

The activity

FGF is a basic protein

Other

RESEARCH COMMUNICATIONS

Effect of EDTA and captopril (SQ 14225) on the ACE activity. The endothelial cells were incubated in the presence of EDTA (1 rnM) or captopril ( 1 uM). Conversion of angiotensin I to The angiotensin II was examined as described in Fig. 1. generated angiotensin II was measured after 3 hr of incubations. Each column represents mean value from three dishes. Bars, S.D.

hormone, or multiplication

cells

AND BIOPHYSICAL

increased

insulin 4).

1214

(data

These observations

lines

number of not

shown).

did not induce ACE activity

an important

converging

cultures,

stimulation

of

role

in

suggest that production

of

evidences suggest that

Vol. 145, No. 3, 1987

Figure

BIOCHEMICAL

AND BIOPHYSICAL

Effect of various factors and in endothelial cells. Confluent

4.

were incubated in factors or hormones to angiotensin II

serum-free for 24 hr. was examined

RESEARCH COMMUNlCATlONS

hormones

on the

ACE activity

cultures of endothelial F-10 medium containing

Conversion as

cells various

of angiotensin

described

in

Fig.

I

1.

The

generated angiotensin II was measured after 5 hr of incubations. Each column represents mean value from three dishes. Bars, S.D.

an action the

of

angiotensin

development

angiotensin given

of arterial system

directly

into

has

been

via

demonstrated

ADH secretion, nervous

the

and

II

produce

has

been

Our

analysis in

the

also

of

of brain,

rise

that

the

cells

pituitary will

physiological thereby

intake.

1215

controlling

angiotensin

arterial

pressure water

in

the

intake, central

FGF increases be the

role

of

ventricles

control

functions

when

types

cerebral in

to

physiological

endothelial

or

renin-

pressure

administration

considered

observations

blood

various

supply

contributes of the

with

a sustained

of

by

lower

animals

blood

system

Antagonists

to

Chronic

to

nervous

(8).

of

cerebral

production

peptide water

(9).

(11).

central

reported

brain

a variety

experimental

endocrine or/and

II

system

angiotensin of

the

either

Angiotensin

(10).

been

hypertesion brain

on the hypertension

have

into

experimental II

II

of

beginning this

blood

neuropressure

Vol. 145, No. 3, 1987

BIOCHEMICAL

AND BIOPHYSICAL

RESEARCH COMMUNICATIONS

REFERENCES 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11.

Okabe, T., and Takaku, F. (1986) Biochem. Biophys. Res. Commun. l34, 344-3.50. Mendelsohn, F.A.O., Lloyd, C.J., Kachel, C., and Funder, J.W. (1982) J. Clin. Invest. 70, 684-692. Booyse, F.M., Sedlak, B.J., and Rafelson, M.E. (1975) Thromb. Diathes. Haemorrh. (stuttg.) 34, 3722-3726. Puck, T.T., Marcus, P.I., and Cieciura, S.J. (1956). J. Exp. Med. 103, 273-289. Okabe, T., Yamagata, K., Fujisawa, M., Watanabe, J., Takaku, F., Lanzillo, J.J., and Fanburg, B.L. (1985) J. Clin. Invest. fi, 911914. Bohlen, P., Baird, A., Esch, F., Ling, F., and Gospodarowicz, D. (1984) Proc. Natl. Acad. Sci. U.S.A. 8l, 5364-5368. Schwartz, S,M. (1978) --In vitro l4, 966-980. Severs, W.B., and Danniels-Severs, A.N. (1973) Pharmcol. Rev. 25, 415-449. Reid, I.A. (1977) Circ. Res. 4l, 147-153. Fukiyama, K., McCubbin, J.W., and Page, I.H. (1971) Clin. Sci. (London) 40, 283-291. Fitzsimons, J.T. (1972) Physiol. Rev. 52, 468-561.

1216